- Home
- GROV vs NSPR Comparison
GROV vs NSPR Comparison
Compare GROV & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- NSPR
- Stock Information
- Founded
- GROV 2016
- NSPR 2005
- Country
- GROV United States
- NSPR Israel
- Employees
- GROV N/A
- NSPR N/A
- Industry
- GROV Package Goods/Cosmetics
- NSPR Medical/Dental Instruments
- Sector
- GROV Consumer Discretionary
- NSPR Health Care
- Exchange
- GROV Nasdaq
- NSPR Nasdaq
- Market Cap
- GROV 56.5M
- NSPR 63.0M
- IPO Year
- GROV N/A
- NSPR N/A
- Fundamental
- Price
- GROV $1.35
- NSPR $2.58
- Analyst Decision
- GROV Buy
- NSPR Buy
- Analyst Count
- GROV 1
- NSPR 1
- Target Price
- GROV $2.00
- NSPR $4.50
- AVG Volume (30 Days)
- GROV 92.7K
- NSPR 35.4K
- Earning Date
- GROV 11-12-2024
- NSPR 11-12-2024
- Dividend Yield
- GROV N/A
- NSPR N/A
- EPS Growth
- GROV N/A
- NSPR N/A
- EPS
- GROV N/A
- NSPR N/A
- Revenue
- GROV $213,781,000.00
- NSPR $6,821,000.00
- Revenue This Year
- GROV N/A
- NSPR $12.28
- Revenue Next Year
- GROV $5.97
- NSPR $53.44
- P/E Ratio
- GROV N/A
- NSPR N/A
- Revenue Growth
- GROV N/A
- NSPR 24.70
- 52 Week Low
- GROV $1.19
- NSPR $1.81
- 52 Week High
- GROV $2.44
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- GROV 49.78
- NSPR 54.15
- Support Level
- GROV $1.30
- NSPR $2.07
- Resistance Level
- GROV $1.41
- NSPR $2.71
- Average True Range (ATR)
- GROV 0.09
- NSPR 0.23
- MACD
- GROV -0.00
- NSPR 0.03
- Stochastic Oscillator
- GROV 30.36
- NSPR 52.04
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.